1. Home
  2. KRUS vs EOLS Comparison

KRUS vs EOLS Comparison

Compare KRUS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Sushi USA Inc.

KRUS

Kura Sushi USA Inc.

HOLD

Current Price

$72.75

Market Cap

845.3M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.16

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRUS
EOLS
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
845.3M
284.3M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
KRUS
EOLS
Price
$72.75
$4.16
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$81.50
$15.50
AVG Volume (30 Days)
231.0K
852.8K
Earning Date
04-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
79.75
1.23
EPS
N/A
N/A
Revenue
$282,763,000.00
$297,176,000.00
Revenue This Year
$21.59
$13.27
Revenue Next Year
$18.29
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
18.88
11.61
52 Week Low
$40.50
$3.86
52 Week High
$95.98
$12.28

Technical Indicators

Market Signals
Indicator
KRUS
EOLS
Relative Strength Index (RSI) 62.24 41.21
Support Level $71.32 $4.10
Resistance Level $78.92 $4.99
Average True Range (ATR) 3.87 0.22
MACD 1.40 -0.06
Stochastic Oscillator 84.61 24.69

Price Performance

Historical Comparison
KRUS
EOLS

About KRUS Kura Sushi USA Inc.

Kura Sushi USA Inc is a technology-enabled Japanese restaurant concept that provides guests with a distinctive dining experience by serving authentic Japanese cuisine through an engaging revolving sushi service model. The company operates a chain of sushi restaurants across the United States serving freshly prepared Japanese cuisine using high-quality ingredients that are free from artificial seasonings, sweeteners, colorings, and preservatives. The company operates a network of dine-in locations across the U.S. states and Washington, DC.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: